Taxotere
Showing 1 - 25 of 829
Advanced Solid Tumors Trial in Cangzhou (Docetaxel for Injection (Albumin-bound), Taxotere)
Active, not recruiting
- Advanced Solid Tumors
- Docetaxel for Injection (Albumin-bound)
- Taxotere
-
Cangzhou, ChinaCangzhou Central Hospital
Jan 27, 2022
Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)
Not yet recruiting
- Breast Cancer
- Nanoxel M
- +3 more
- (no location specified)
Jan 20, 2022
Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),
Recruiting
- Gastric Adenocarcinoma
- Adenocarcinoma of Gastroesophageal Junction
- Docetaxel for injection (Albumin-bound)
- Taxotere
-
Guangzhou, ChinaEthics Committee of Sun-Yat-Sen University Cancer Center
Jan 27, 2023
Pancreatic Cancer Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)
Completed
- Pancreatic Cancer
- Gemcitabine
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 29, 2021
Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Gemcitabine, Taxotere, Xeloda)
Completed
- Metastatic Pancreatic Adenocarcinoma
- Gemcitabine
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 9, 2021
Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)
Recruiting
- Recurrent Non-small Cell Lung Cancer
- Cisplatin
- +7 more
-
Changchun, Jilin, China
- +2 more
May 3, 2022
Prostate Cancer Trial in San Francisco, Houston (Docetaxel, Carboplatin, Etoposide)
Breast Cancer Trial in Houston (Taxotere/Docetaxel, Adriamycin/Cytoxan, doxorubicin)
Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine
- +2 more
- (no location specified)
Sep 9, 2022
Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)
Active, not recruiting
- Prostatic Neoplasms
-
Copenhagen, Denmark
- +4 more
Aug 12, 2021
NSCLC Trial (Pembrolizumab, Docetaxel)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Pembrolizumab
- Docetaxel
- (no location specified)
Aug 18, 2022
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in Seattle
Terminated
- Castration-Resistant Prostate Carcinoma
- +3 more
- Carboplatin
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 3, 2021
Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)
Not yet recruiting
- Effect of Drug
-
Sapporo, Hokkaido, JapanHokkaido University Hospital
Feb 12, 2022
Thyroid Cancer, Salivary Gland Cancer Trial in Chicago (Pembrolizumab, Docetaxel)
Recruiting
- Thyroid Cancer
- Salivary Gland Cancer
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 13, 2022
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)
Completed
- Prostate Cancer
- docetaxel
- sorafenib tosylate
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 16, 2022
Breast Cancer Trial in Los Angeles (trastuzumab, carboplatin, docetaxel)
Completed
- Breast Cancer
- trastuzumab
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020
Catheter Related Complications Trial in Stockholm (FEC75 (or EC90) x 6, FEC100 + Taxotere (EC90 + Taxotere) 3+3, Paclitaxel)
Completed
- Catheter Related Complications
- FEC75 (or EC90) x 6
- +2 more
-
Stockholm, SwedenOnkologiska kliniken, Karolinska University Hospital, Danderyd H
Mar 16, 2021
Peritoneal Carcinomatosis Trial in Baltimore (Intraperitoneal docetaxel)
Recruiting
- Peritoneal Carcinomatosis
- Intraperitoneal docetaxel
-
Baltimore, MarylandJohns Hopkins University
Nov 8, 2021